07 Jan 2001

Bonifen 300 - España

Updated: 07 Jan 2001

Bonifen 300 mg 30 capsulas

Autorizadas en España: Astenia. Insuficiencia cerebrovascular.

Bonifen 300 Description, Presentation and Dosage

Bonifen 300 Description

Bonifen 300 Drug Class Description

Psicoestimulantes

Bonifen 300 Drug Description

CAPSULAS

Bonifen 300 Presentation

Bonifen 300 Presentation

Oral. Adultos: 100 mg/8 h, pudiendo incrementarse la dosis diaria, en función de la respuesta clínica, hasta un máximo de 300 mg/8 h (900 mg/día). Niños (>2 años): hasta 480 mg/día. Niños (<2 años): hasta 160 mg/día. La administración de la última dosis diaria se aconseja hacerla antes de las cinco de la tarde, a fin de reducir la incidencia de insomnio.

Bonifen 300 Manufacturer

MERCK FARMA QUIMICA

Related Learning Zones

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Bonifen 300 Dosage

Bonifen 300 Precautions, Reactions and Contraindications

Bonifen 300 Special Precautions

Bonifen 300 Adverse Reactions

Bonifen 300 Adverse Reactions

Los efectos adversos de este medicamento son, en general, infrecuentes aunque moderadamente importantes. Las reacciones adversas más características son: -Raramente (<1%): náuseas, vómitos, gastralgia, insomnio, excitación y agitación. -Excepcionalmente (<<1%): alteraciones renales (proteinuria, síndrome nefrótico) y alteraciones hematológicas (leucopenia, trombocitopenia) en tratamientos prolongados con dosis elevadas (900 mg/día de piritinol).

Related Drugs - Medicina tropical

Back to top